Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 64/100

Termination Rate

28.6%

6 terminated out of 21 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

24%

5 trials in Phase 3/4

Results Transparency

42%

5 of 12 completed with results

Key Signals

5 with results67% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (4)
P 1 (3)
P 2 (6)
P 3 (3)
P 4 (2)

Trial Status

Completed12
Terminated6
Unknown3

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT03630718Not ApplicableCompletedPrimary

Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women

NCT03468699Phase 2CompletedPrimary

Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia

NCT00550862Phase 2TerminatedPrimary

Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)

NCT02308111Phase 4TerminatedPrimary

Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis

NCT03265249Not ApplicableTerminated

BRIDGE Device for Post-operative Pain Control

NCT03633227Phase 4TerminatedPrimary

Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment

NCT04047160Phase 1Completed

Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)

NCT02936596Not ApplicableUnknown

Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome

NCT00570765Phase 2CompletedPrimary

Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)

NCT04629456Not ApplicableCompletedPrimary

Physical Therapy for Liver Cirrhosis

NCT02917408Completed

Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital

NCT03476993Phase 2TerminatedPrimary

Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis

NCT00125281Phase 2TerminatedPrimary

SAMe to Treat Biliary Cirrhosis Symptoms

NCT00004842Phase 1Completed

Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

NCT00406237Phase 1CompletedPrimary

Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis

NCT00058903Phase 2Completed

Treatment of Cholestatic Pruritus With Sertraline

NCT00006168Phase 3CompletedPrimary

Ursodiol-Methotrexate for Primary Biliary Cirrhosis

NCT00160940Unknown

Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis

NCT00145964UnknownPrimary

Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)

NCT00004748Phase 3CompletedPrimary

Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis

Scroll to load more

Research Network

Activity Timeline